Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Poor Performance Status”

45 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 45 results

Testing effectiveness (Phase 2)UnknownNCT01676558
What this trial is testing

A Phase II Study of 131I-rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)

Who this might be right for
Relapsed or Refractory Diffuse Large B Cell Lymphoma
Korea Cancer Center Hospital 24
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Large-scale testing (Phase 3)Study completedNCT00259064
What this trial is testing

Iressa v BSC (Best Supportive Care) in First Line NSCLC

Who this might be right for
NSCLC
AstraZeneca 216
Large-scale testing (Phase 3)Study completedNCT01459497
What this trial is testing

Hypofractionated Image-Guided Radiation Therapy (IGRT) in Patients With Stage II-III Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
University of Texas Southwestern Medical Center 103
Large-scale testing (Phase 3)Study completedNCT00040885
What this trial is testing

Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05)

Who this might be right for
AnorexiaCachexiaFatigue+1 more
Alliance for Clinical Trials in Oncology 67
Not applicableStudy completedNCT03623334
What this trial is testing

Phase I Study of Accelerated Hypofractionated Image-Guided Radiation Therapy

Who this might be right for
Non-small Cell Lung Cancer
University of Texas Southwestern Medical Center 55
Not applicableStudy completedNCT00445731
What this trial is testing

A Structured Walking Program or Standard Therapy in Cancer Patients Undergoing a Donor Bone Marrow Transplant

Who this might be right for
Cancer
University of Minnesota 115
Testing effectiveness (Phase 2)Study completedNCT00193336
What this trial is testing

Iressa in Poor Performance Status Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
SCRI Development Innovations, LLC 60
Testing effectiveness (Phase 2)Study completedNCT04221529
What this trial is testing

Patients With ES-SCLC and ECOG PS=2 Receiving Atezolizumab-Carboplatin-Etoposide

Who this might be right for
SCLC, Extensive Stage
AIO-Studien-gGmbH 70
Testing effectiveness (Phase 2)Study completedNCT01415011
What this trial is testing

Efficacy and Safety Study of Afatinib to Treat Lung Cancer Patients

Who this might be right for
Carcinoma, Non-Small-Cell Lung
University College, London 39
Not applicableStudy completedNCT00336258
What this trial is testing

US-Doppler and Procoagulant Microparticles for the Diagnosis of Asymptomatic DVT in Advanced Cancer Patients With Poor Performance Status

Who this might be right for
Deep Vein ThrombosisCancer
Rambam Health Care Campus 100
Testing effectiveness (Phase 2)Looking for participantsNCT05589818
What this trial is testing

Pembrolizumab for Advanced NSCLC and PS 2-3

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Icahn School of Medicine at Mount Sinai 45
Early research (Phase 1)Ended earlyNCT00287859
What this trial is testing

Topotecan in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
Masonic Cancer Center, University of Minnesota 5
Testing effectiveness (Phase 2)Study completedNCT00124618
What this trial is testing

Cetuximab and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 58
Not applicableUnknownNCT01882335
What this trial is testing

Saving Brain in Uganda and Burkina Faso

Who this might be right for
Poor Performance StatusNeurologic DeficitsMixed Behavior and Emotional Disorder+2 more
Makerere University 600
Testing effectiveness (Phase 2)Study completedNCT00193323
What this trial is testing

Weekly Docetaxel Versus Weekly Docetaxel/Gemcitabine in the Treatment of Non-Small Cell Lung Cancer in Elderly Patients

Who this might be right for
Lung Cancer
SCRI Development Innovations, LLC 346
Not applicableStudy completedNCT02160873
What this trial is testing

Nighttime Feeding and Morning Endurance Performance

Who this might be right for
Poor Performance Status
Florida State University 12
Not applicableStudy completedNCT01704976
What this trial is testing

SR-WBV Training for Frail Elderly in the Skilling up Stage

Who this might be right for
Poor Performance StatusMuscle Weakness
Bern University of Applied Sciences 27
Testing effectiveness (Phase 2)Study completedNCT00891878
What this trial is testing

Capecitabine With or Without Sunitinib Malate as First-Line Therapy in Treating Patients With Metastatic Cancer of the Esophagus or Gastroesophageal Junction

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionEsophageal Cancer
Alliance for Clinical Trials in Oncology 12
Testing effectiveness (Phase 2)Study completedNCT04108026
What this trial is testing

Immunotherapy in Patient With Poor General Condition

Who this might be right for
Non-small Cell Lung Cancer Stage IV
Intergroupe Francophone de Cancerologie Thoracique 50
Load More Results